Casper Sleep Cuts IPO Price While Beam Lifts Target
Law360 (February 5, 2020, 4:11 PM EST) -- Mattress company Casper Sleep on Wednesday downsized its expectations for its Latham-steered initial public offering, while biotechnology company Beam Therapeutics bulked up its plans for its Ropes & Gray-steered debut.
Casper Sleep Inc. said it now expects its 8.35 million shares to price between $12 and $13 apiece, setting up the online mattress seller to raise about $104 million if its shares price at midpoint. Casper had previously estimated a $17 to $19 per-share price.
Beam Therapeutics Inc., meanwhile, increased the number of shares on offer from 6.25 million to 9.25 million, setting it up to bring in an additional $48...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!